文献速递胸部肿瘤放疗放疗物理与技术

早期非小细胞肺癌SABR后无局部复发患者高危影像特征的发生率

Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-09-22

本研究回顾性分析了2008至2013年接受VMAT-SABR的88例早期NSCLC患者共747次CT随访扫描,由5名对临床结局不知情的临床医生评估高危影像特征(HRFs)。在确认无局部复发的患者中,超过50%出现HRFs,近25%出现≥3个HRFs,提示现行随访建议需进一步细化。

要点

  • 无局部复发的SABR后患者中,超过50%出现高危影像特征。
  • 扩大性密度增高影(EO)最常见,≥3名观察者记录达64.8%。
  • 22.7%的无复发患者出现≥3个HRFs,与复发风险特征重叠。

核心结论

  • 超过50%的SABR后无局部复发患者出现高危影像特征,近25%出现≥3个HRFs,需进一步细化随访建议。

研究设计与样本

  • 回顾性分析2008至2013年接受VMAT-SABR的早期NSCLC患者,纳入随访≥2年且无局部复发者,共88例患者747次CT扫描。
  • 5名对临床结局不知情的临床医生使用ClearCanvas附加工具在工作站审阅所有扫描并评分HRFs。

主要发现

  • ≥3名观察者至少在1次随访扫描中记录的HRFs:EO 64.8%、EO12 50.0%、sequential EO 13.6%。
  • 76例随访1年后出现EO的患者中,30例此前未出现EO。
  • 22.7%的患者CT扫描中观察到≥3个HRFs(既往认为与复发相关)。
  • 常规诊疗中,6例因怀疑局部复发接受PET扫描,4例尝试活检。

临床怎么用

  • SABR后无局部复发的患者常出现HRFs,解读影像时应结合系列变化而非单一特征。
  • ≥3个HRFs在近25%无复发患者中存在,提示该阈值单独用于诊断复发特异性有限。

局限性

  • 回顾性设计,仅纳入随访≥2年且有CT扫描的患者,可能存在选择偏倚。
  • 样本量88例,HRFs评估依赖观察者评分,未报告观察者间一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate, in the setting of stereotactic ablative radiation therapy (SABR) for early-stage non-small cell lung cancer, the incidence and patterns of change in high-risk radiologic features (HRFs) in patients known to have no local recurrence. METHODS AND MATERIALS: Computed tomography (CT) scans of patients treated using volumetric modulated arc therapy SABR between 2008 and 2013 were eligible if follow-up scans were available for 2 years and no local recurrences were diagnosed. All scans were reviewed at a workstation using an add-on tool for ClearCanvas (Synaptive Medical). Five clinicians who were blinded to clinical outcomes scored the presence of HRFs: enlarging opacity (EO), sequential enlarging opacity, enlarging opacity after 12 months (EO12), bulging margin, loss of linear margins, cranio-caudal growth, and loss of air bronchogram. After each review, clinicians recommended follow-up procedures based on published recommendations. RESULTS: A total of 88 patients (747 CT scans) were evaluated. The HRFs most frequently recorded by ≥3 observers on at least 1 follow-up scan were EO (64.8%), EO12 (50.0%), and sequential enlarging opacity (13.6%). Fifty-six patients developed EO within the first year after SABR, and of these, 46 also developed subsequent EO (EO12). In 76 patients who developed EO after 1 year of follow-up, 30 had not manifested EO previously. Three or more HRFs have been associated with recurrences, and this was observed on CT scan in 22.7% of patients. In their routine care, 6 patients had undergone a positron emission tomography scan because of a suspected local recurrence, and 4 underwent an attempt at biopsy. CONCLUSIONS: More than 50% of patients without a local recurrence after SABR develop HRFs. Because ≥3 HRFs were present in nearly 25% of patients, further refinement of follow-up recommendations are necessary.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Ronden MI, van Sörnsen de Koste JR, Johnson C, et al. Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017. PMID: 29102278. doi:10.1016/j.ijrobp.2017.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。